Methotrexate Injection is a folate analog metabolic inhibitor indicated for: The following neoplastic diseases for the: o Treatment of adult and pediatric patients with acute lymphoblastic leukemia as part of a combination chemotherapy regimen. o Prophylaxis and treatment of adult and pediatric patients with meningeal leukemia.
From the U.S. FDA-approved label for Methotrexate. Full label: DailyMed.
Methotrexate Injection is a folate analog metabolic inhibitor indicated for: The following neoplastic diseases for the: o Treatment of adult and pediatric patients with acute lymphoblastic leukemia as part of a combination chemotherapy regimen. o Prophylaxis and treatment of adult and pediatric patients with meningeal leukemia. o Treatment of adult and pediatric patients with osteosarcoma as part of a combination chemotherapy regimen. o Treatment of adults with squamous cell carcinoma of the head and neck as a single agent.
From the U.S. FDA-approved label for Methotrexate. Full label: DailyMed.
Verify pregnancy status in females of reproductive potential before starting Methotrexate Injection., Neoplastic diseases: Refer to the prescribing information for disease specific dosing recommendations.
Directions from the U.S. FDA-approved label for Methotrexate — your doctor or pharmacist may advise differently.
Methotrexate Injection is contraindicated in: Patients with history of severe hypersensitivity to methotrexate., Pregnancy in patients with non-neoplastic diseases., History of severe hypersensitivity to methotrexate., Pregnancy: in patients with non-neoplastic diseases.
Excerpt from the U.S. FDA-approved label for Methotrexate. Talk to a pharmacist or doctor before use.
Secondary malignancies can occur., Tumor lysis syndrome can occur in patients with rapidly growing tumors., Immunizations and Risks associated with Live Vaccines: Immunizations may be ineffective. Live vaccines are not recommended due to risk of disseminated infection., Infertility: Can cause impairment of fertility, oligospermia, and menstrual dysfunction. 5.1 Embryo-Fetal Toxicity Based on published reports and its mechanism of action, methotrexate can cause embryo-fetal toxicity, including fetal death when administered to a pregnant woman.
Warnings and precautions excerpt from the U.S. FDA-approved label for Methotrexate — not a complete list. Talk to a pharmacist or doctor before use.
The following adverse reactions are described, or described in greater detail, in other sections: Hypersensitivity Reactions, Myelosuppression, Serious Infections, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Gastrointestinal Toxicity, Pulmonary Toxicity, Dermatologic Reactions, Secondary Malignancies, Tumor Lysis Syndrome, Increased Risk of Adverse Reactions due to Third-Space Accumulation Common adverse reactions include…
Excerpt from the U.S. FDA-approved label for Methotrexate — not a complete list. Talk to a pharmacist or doctor about side effects.
16 brands · 6 makers in the NepalDoc catalog — see the full Methotrexate guide →
Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Protect from light. After first puncture, store multiple-dose vials at 2°C to 8°C, and use within 30 days. Methotrexate Injection is a hazardous drug. Follow applicable special handling and disposal procedures.
Storage information from the U.S. FDA-approved label for Methotrexate.
What is Biotrexate?
Biotrexate 2.5mg Tablet is a Methotrexate medicine made by Biochem Pharmaceuticals Industries Limited. It comes as 2.5mg Tablet.
What is Biotrexate used for?
According to its FDA label, Methotrexate is used for the following neoplastic diseases for the: o.
What is the generic name of Biotrexate?
The generic name of Biotrexate is Methotrexate.
Which brands of Methotrexate are available in Nepal?
16 brands of Methotrexate are listed in the NepalDoc catalog, from 6 makers — including C-Methocel 50mg Injection, Imutrex 2.5mg Tablet, Imutrex 30mg Injection, Imutrex 7.5mg Tablet, Imutrex 10mg Tablet, Oncotrex 2.5mg Tablet.
What are the side effects of Methotrexate?
The following adverse reactions are described, or described in greater detail, in other sections: Hypersensitivity Reactions, Myelosuppression, Serious Infections, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Gastrointestinal Toxicity, Pulmonary Toxicity, Dermatologic Reactions, Secondary Malignancies, Tumor Lysis Syndrome, Increased Risk of Adverse Reactions due to Third-Space Accumulation Common adverse reactions include…
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
Every NepalDoc section, one tap away.
Find doctors by specialty across Nepal.
